2025 Q2 Paraguay Pharmaceutical products (HS3004) Export Snapshot: Surge & Dominance

Q2 Trend: Paraguay Pharmaceutical products Export

Pharmaceutical products, classified under HS Code 3004 (Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail sale.), saw mixed trends in Q2 2025. After a 30.59% drop in export value in April, shipments rebounded with a 7.01% rise in May and a sharper 24.42% jump in June, reaching $7.52M. Unit prices fluctuated, dipping 12.21% in April before climbing 16.08% to $47.62/kg by June. Export volumes grew steadily, peaking at 157.89K kg in June, up 7.18% from May. The March surge in value (+147.27%) suggests potential policy impacts, though no specific drivers were confirmed in Q2.

Table: Paraguay Pharmaceutical Products Export Trend (Source: yTrade)

Get Paraguay Pharmaceutical Products Historical Export Data

Geographic Concentration & Market Logic

Panama dominates Paraguay's pharmaceutical exports with an 18.94% value share but only 9.20% weight share, signaling a premium market demanding high-grade or finished products. Peru follows closely, with a 20.04% weight share (vs. 18.59% value), acting as a bulk hub for raw materials or intermediates. The value-volume gap reveals a dual strategy: Panama drives margins, while Peru absorbs volume. This structure suggests a supply chain optimized for segmented demand, balancing premium and cost-sensitive markets. Brazil’s outlier role (3.96% value vs. 0.52% weight) hints at niche high-value exports.

Table: Paraguay Pharmaceutical Products (HS Code 3004) Top Destination Countries (Source: yTrade)

Get Complete Paraguay Pharmaceutical Products Destination Countries Profile

Paraguay HS Code 3004 Breakdown & Value Logic

yTrade data reveals HS Code 30049069 dominates Paraguay's Q2 2025 pharmaceutical exports, capturing 27% of shipments and 22.5% of value, despite its mid-tier volume share (29.8%). The remaining sub-codes—largely similar retail-packaged medicaments—show fragmented demand, with 30049059 and 30049079 trailing in value but highlighting niche premiums. This Paraguay HS Code 3004 Export pattern suggests a market prioritizing mid-range pricing with broad accessibility, not pure volume or luxury. The absence of unit prices implies competitive positioning rather than premium branding, reinforcing a bulk-driven, cost-sensitive trade flow.

Table: Paraguay (HS Code 3004) Breakdown Details (Source: yTrade)

Check Detailed HS Code 3004 Breakdown

Paraguay Pharmaceutical Products Buyers List

Table: Paraguay Pharmaceutical Products (HS Code 3004) Top Buyers List (Source: yTrade)

Check Full Pharmaceutical products Buyers list

Frequently Asked Questions

How did Paraguay Pharmaceutical products Export perform in Q2?

Exports surged 24.42% month-on-month in June, reaching $7.52M, with unit prices up 16.08% to $47.62/kg.

What are the top Export partners for Paraguay Pharmaceutical products?

Panama ($3.64M), Peru ($3.57M), and Ecuador ($2.54M) were the top destinations.

Who are the major Pharmaceutical products Buyers?

Adium Pharma S.A dominated with $6.57M in purchases, accounting for 87% of the tracked buyer cluster value.

What is the specific HS Code for this trade?

The data covers HS Code 3004, with significant activity in medicaments packaged for retail sale (300490**).

Detailed Monthly Report

Paraguay HS3004 Export Snapshot 2025 APR

Paraguay HS3004 Export Snapshot 2025 MAY